Ntokozo Msiza
Publishes 1 feed
SAHPRA
South African Health Products Regulatory Authority
10 posts · contributor
Lately
The South African Health Products Regulatory Authority reaffirms the safety of routine childhood vaccination
SAHPRA ·
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes
SAHPRA ·
SAHPRA inspires TUT students to pursue careers in health regulation
SAHPRA ·
SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure
SAHPRA ·
SAHPRA Inspires Rhodes Science Students to Shape the Future of Health Regulation
SAHPRA ·
Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide
SAHPRA ·
Protecting Patients: Ensuring Safe, Quality and Effective Health Products
SAHPRA ·
SAHPRA strengthens industry collaboration to improve access to safe medicines
SAHPRA ·
SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1/ GIP Medicines
SAHPRA ·
SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns
SAHPRA ·
Everything on this page was read from markup Ntokozo Msiza published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON
